<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> (LS), an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> inherited <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility syndrome, also known as hereditary non-<z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (HNPCC), is caused by a germline mutation in one of several DNA mismatch repair (MMR) genes </plain></SENT>
<SENT sid="1" pm="."><plain>LS is the most common presentation of hereditary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), accounting for about 2-5% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases </plain></SENT>
<SENT sid="2" pm="."><plain>More recently, it is found that a similar number of <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancers</z:e> is also due to one of the MMR gene mutations </plain></SENT>
<SENT sid="3" pm="."><plain>There has been significant progress in LS-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in terms of molecular pathogenesis, risks, genetic basis, and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, the advance about LS-related <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> (EC) is very much limited </plain></SENT>
<SENT sid="5" pm="."><plain>In this commentary, we summarize the main clinicopathologic features of LS-related EC and propose universal screening for LS in individuals with <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> </plain></SENT>
</text></document>